Back
Arcutis Biotherapeutics Stock Price Chart
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
9.86
Seasonality Move:
-24.31%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- The current trend is moderately bearish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.
Arcutis Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.45 | Sell |
| 20-day SMA: | 10.42 | Sell |
| 50-day SMA: | 9.92 | Buy |
| 200-day SMA: | 8.19 | Buy |
| 8-day EMA: | 10.38 | Sell |
| 20-day EMA: | 10.27 | Sell |
| 50-day EMA: | 9.92 | Buy |
| 200-day EMA: | 8.96 | Buy |
Arcutis Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 49.58 | Sell |
| Chaikin Money Flow: | -3424863 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.11 - 10.95) | Buy |
| Bollinger Bands (100): | (8.34 - 10.3) | Buy |
Arcutis Biotherapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arcutis Biotherapeutics Stock
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 10.14 while ARQT 8-day simple moving average is 10.45, which is a Sell signal.
- The stock price of ARQT is 10.14 while Arcutis Biotherapeutics 20-day SMA is 10.42, which makes it a Sell.
- Arcutis Biotherapeutics 50-day simple moving average is 9.92 while ARQT share price is 10.14, making it a Buy technically.
- ARQT stock price is 10.14 and Arcutis Biotherapeutics 200-day simple moving average is 8.19, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy or a Sell?
-
Arcutis Biotherapeutics stock is rated a Sell
The current Arcutis Biotherapeutics [ARQT] share price is $10.14. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Arcutis Biotherapeutics Stock Info
Market Cap:
1.19B
Price in USD:
10.14
Share Volume:
4.15M
Arcutis Biotherapeutics 52-Week Range
52-Week High:
13.17
52-Week Low:
1.76
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Arcutis Biotherapeutics Share Price Forecast
-
What is the Arcutis Biotherapeutics stock price today?
The Arcutis Biotherapeutics stock price is 10.14 USD today. -
Will ARQT stock go up or go down?
Arcutis Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Arcutis Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics is overvalued.
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 10.14 while ARQT 8-day exponential moving average is 10.38, which is a Sell signal.
- The stock price of ARQT is 10.14 while Arcutis Biotherapeutics 20-day EMA is 10.27, which makes it a Sell.
- Arcutis Biotherapeutics 50-day exponential moving average is 9.92 while ARQT share price is 10.14, making it a Buy technically.
- ARQT stock price is 10.14 and Arcutis Biotherapeutics 200-day simple moving average is 8.96, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics
Is Arcutis Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.
Technical Analysis of Arcutis Biotherapeutics
Should I short Arcutis Biotherapeutics stock?
- ARQT Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Arcutis Biotherapeutics is a Buy
- Arcutis Biotherapeutics Relative Strength Index (RSI) is 49.58, which suggest Arcutis Biotherapeutics is oversold
- The Bollinger Bands (25) for Arcutis Biotherapeutics is (9.11 - 10.95), which suggest Arcutis Biotherapeutics is a Buy
- The Bollinger Bands (100) for Arcutis Biotherapeutics is (8.34 - 10.3), which suggest Arcutis Biotherapeutics is a Buy
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.